- Home
- A-Z Publications
- Current Pharmaceutical Design
- Previous Issues
- Volume 17, Issue 22, 2011
Current Pharmaceutical Design - Volume 17, Issue 22, 2011
Volume 17, Issue 22, 2011
-
-
Editorial [Hot Topic: Architecture and Design of Non-Drug Therapy for Reactive Oxygen Spcecies (ROS)-Induced Diseases (Executive Guest Editors: Tohru Yoshioka and Mami Noda)]
Authors: Tohru Yoshioka and Mami NodaIt is generally accepted that ROS is major cause of life style-dependent diseases such as cancer, stroke and many other serious diseases. So far they were treated individually by various kinds of drugs specially designed for each symptom, but these approaches must be changed innovatively. Generally, ROS is generated intracellularly when mitochondria is producing ATP, while it is also generated extracellularly by the stimulati Read More
-
-
-
Recent Progress Toward Hydrogen Medicine: Potential of Molecular Hydrogen for Preventive and Therapeutic Applications
By Shigeo OhtaPersistent oxidative stress is one of the major causes of most lifestyle-related diseases, cancer and the aging process. Acute oxidative stress directly causes serious damage to tissues. Despite the clinical importance of oxidative damage, antioxidants have been of limited therapeutic success. We have proposed that molecular hydrogen (H2) has potential as a “novel” antioxidant in preventive and therapeutic applicatio Read More
-
-
-
The Principle and the Potential Approach to ROS-dependent Cytotoxicity by Non-pharmaceutical Therapies: Optimal Use of Medical Gases with Antioxidant Properties
Authors: Mami Noda, Kyota Fujita, Chih-Hung Lee and Tohru YoshiokaRegulation of cellular redox balances is important for the homeostasis of human health. Thus, many important human diseases, such as inflammation, diabetes, glaucoma, cancers, ischemia and neurodegenerative diseases, have been investigated in the field of reactive oxygen species (ROS) and oxidative stress. To overcome the harmful effect of oxidative stress and ROS, one can directly eliminate them by med Read More
-
-
-
The Possible Involvement of Glycogen Synthase Kinase-3 (GSK-3) in Diabetes, Cancer and Central Nervous System Diseases
Authors: Amar S., Belmaker R.H. and Agam G.Glycogen synthase kinase (GSK-3) is a key enzyme in multiple cell processes. Since many pharmacological compounds that have effects on common metabolic pathways may have uses in many different diseases, we review here the possible involvement of glycogen synthase kinase 3 in diabetes, cancer and CNS diseases. Moreover, diabetes has recently been strongly linked to CNS diseases such as schizophrenia and bip Read More
-
-
-
Jun Dimerization Protein 2 in Oxygen Restriction; Control of Senescence
Senescent cells show a series of alterations, including a flat and enlarged morphology, increase in nonspecific acidic β- galactosidase activity, chromatin condensation, and changes in gene expression patterns. The onset and maintenance of senescence are regulated by two tumor suppressor proteins, p53 and Rb, whose expression is controlled by two distinct proteins, p19Arf and p16Ink4a, respectively, which are e Read More
-
-
-
Walking the Oxidative Stress Tightrope: A Perspective from the Naked Mole-Rat, the Longest-Living Rodent
Reactive oxygen species (ROS), by-products of aerobic metabolism, cause oxidative damage to cells and tissue and not surprisingly many theories have arisen to link ROS-induced oxidative stress to aging and health. While studies clearly link ROS to a plethora of divergent diseases, their role in aging is still debatable. Genetic knock-down manipulations of antioxidants alter the levels of accrued oxidative damage, however, the re Read More
-
-
-
Metallodendrimers and Dendrimer Nanocomposites
Authors: Yi-Hsuan Tang, Adela Ya-Ting Huang, Po-Yu Chen, Hui-Ting Chen and Chai-Lin KaoDendrimers are polymeric compounds with highly branched structures and functionally tunable peripheral groups. Because of their low polydispersity, high degree of molecular uniformity, and precisely controlled structure, dendrimers are excellent models for demonstrating a variety of biological activities. With the attachment of metals ions and/or metals, metallodendrimers or dendrimer nanocomposites, resp Read More
-
-
-
Design of Magnetic Nanoparticles-Assisted Drug Delivery System
Authors: Guo-Jing Chen and Li-Fang WangMagnetic nanoparticles (MNPs) have been designed for multifaceted applications such as contrast agents in magnetic resonance imaging (MRI) diagnosis, drug/gene carriers for different kinds of therapeutic agents, tissue repair, hyperthermia, immunoassay, and cell separation/sensing. This review highlights synthesis methods, stabilizers used for surface coating on MNPs, and target ligands for ferrying payloads to an interest Read More
-
-
-
Gas Bioengineering Using Hemoglobin-Vesicles For Versatile Clinical Applications
Authors: Hiromi Sakai, Shinji Takeoka and Koichi KobayashiBlood transfusion systems have greatly benefited human health and welfare. Nevertheless, some problems remain: possibility of infection, blood type mismatching, immunological response, and a short shelf life that is insufficient for stockpiling for emergency situations. Realization of artificial O2 carriers is anticipated to solve such problems. During the long development of hemoglobin (Hb)-based O2 carriers, many side effects Read More
-
-
-
Development of Microwave Antennas for Thermal Therapy
Authors: Koichi Ito and Kazuyuki SaitoThere are several different ways for cancer treatment including operation, radiation therapy, chemotherapy, gene therapy, immunotherapy, ablation and hyperthermia. Techniques utilizing temperature elevation over the tumor region are usually called as thermal therapies. In this paper, we will focus on hyperthermia which is one of the promising cancer treatments utilizing the difference of thermal sensitivity between the Read More
-
-
-
Corrigendum
More LessWillis, CL and Davis TP. Chronic Inflammation Pain and the Neurovascular Unit: A Central Role for Glia in Maintaining BBB Integrity. Curr Pharm Des 2008, 14: 1625-1643. Erroneously, there was an omission of Brooks, TA in the authorship for the submitted manuscript. The author list should instead read: Willis, CL, Brooks, TA and Davis TP.
-
Volumes & issues
-
Volume 31 (2025)
-
Volume 30 (2024)
-
Volume 29 (2023)
-
Volume 28 (2022)
-
Volume 27 (2021)
-
Volume 26 (2020)
-
Volume 25 (2019)
-
Volume 24 (2018)
-
Volume 23 (2017)
-
Volume 22 (2016)
-
Volume 21 (2015)
-
Volume 20 (2014)
-
Volume 19 (2013)
-
Volume 18 (2012)
-
Volume 17 (2011)
- Issue 38
- Issue 37
- Issue 36
- Issue 35
- Issue 34
- Issue 33
- Issue 32
- Issue 31
- Issue 30
- Issue 29
- Issue 28
- Issue 27
- Issue 26
- Issue 25
- Issue 24
- Issue 23
- Issue 22
- Issue 21
- Issue 20
- Issue 19
- Issue 18
- Issue 17
- Issue 16
- Issue 15
- Issue 14
- Issue 13
- Issue 12
- Issue 11
- Issue 10
- Issue 9
- Issue 8
- Issue 7
- Issue 6
- Issue 5
- Issue 4
- Issue 3
- Issue 2
- Issue 1
-
Volume 16 (2010)
-
Volume 15 (2009)
-
Volume 14 (2008)
-
Volume 13 (2007)
-
Volume 12 (2006)
-
Volume 11 (2005)
-
Volume 10 (2004)
-
Volume 9 (2003)
-
Volume 8 (2002)
-
Volume 7 (2001)
-
Volume 6 (2000)
Most Read This Month
Article
content/journals/cpd
Journal
10
5
false
en
